BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11034825)

  • 1. A multi-stage model of adenoma development.
    Pinsky PF
    J Theor Biol; 2000 Nov; 207(2):129-43. PubMed ID: 11034825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients.
    Bjerknes M; Cheng H; Kim H; Schnitzler M; Gallinger S
    Cancer Res; 1997 Feb; 57(3):355-61. PubMed ID: 9012454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological bases of the colorectal adenoma-carcinoma sequence].
    Stella S; Bruzzese A; Chiarini S
    G Chir; 1996 Oct; 17(10):473-6. PubMed ID: 9044597
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of adenomas among young individuals at average risk for colorectal cancer.
    de Jong AE; Morreau H; Nagengast FM; Mathus-Vliegen EM; Kleibeuker JH; Griffioen G; Cats A; Vasen HF
    Am J Gastroenterol; 2005 Jan; 100(1):139-43. PubMed ID: 15654793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrilysin gene expression in sporadic and familial colorectal adenomas.
    Takeuchi N; Ichikawa Y; Ishikawa T; Momiyama N; Hasegawa S; Nagashima Y; Miyazaki K; Koshikawa N; Mitsuhashi M; Shimada H
    Mol Carcinog; 1997 Aug; 19(4):225-9. PubMed ID: 9290698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas.
    Jones S; Lambert S; Williams GT; Best JM; Sampson JR; Cheadle JP
    Br J Cancer; 2004 Apr; 90(8):1591-3. PubMed ID: 15083190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
    Al-Sukhni W; Aronson M; Gallinger S
    Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary colorectal cancer syndromes.
    Guanti G; Bukvić N
    Acta Chir Iugosl; 2000; 47(4 Suppl 1):23-5. PubMed ID: 11432238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
    Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
    Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Colorectal carcinogenesis: update].
    Lièvre A; Laurent-Puig P
    Rev Prat; 2004 Jan; 54(2):143-50. PubMed ID: 15086056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.
    Lindgren G; Liljegren A; Jaramillo E; Rubio C; Lindblom A
    Gut; 2002 Feb; 50(2):228-34. PubMed ID: 11788565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of new screening protocol on individuals at increased risk of colorectal cancer.
    Mak T; Senevrayar K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2007 Sep; 9(7):635-40. PubMed ID: 17824981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apoptosis during development of colorectal cancer.
    Bedi A; Pasricha PJ; Akhtar AJ; Barber JP; Bedi GC; Giardiello FM; Zehnbauer BA; Hamilton SR; Jones RJ
    Cancer Res; 1995 May; 55(9):1811-6. PubMed ID: 7728743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited disorders associated with colorectal cancer.
    Murday V; Slack J
    Cancer Surv; 1989; 8(1):139-57. PubMed ID: 2680068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of hereditary colon cancer.
    Rustgi AK
    Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.